| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Teva Pharmaceutical Industries Ltd (TEVA) has 22 insiders with recent SEC Form 4 filings, including 1 buy and 10 sells. TEVA is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 426.3K | $15.23M | - | |
| CFO | 403.3K | $14.41M | - | |
| Dir | 367.6K | $13.13M | - | |
| VP | 148.8K | $5.32M | - | |
| Dir | 115.7K | $4.13M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 | Weiss Amir | Chief Accounting Officer | Sell | 12,300 | $30.20 | $371,504.28 | -68.5% | -2.1% | - | |
| Dec 16, 2025 | Mignone Roberto | Director | Sell | 77,400 | $30.24 | $2,340,645.66 | -17.4% | -2.1% | - | |
| Dec 9, 2025 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 115,468 | $28.68 | $3,311,125.73 | -70.5% | +10.3% | - | |
| Dec 9, 2025 | Sabag Mark | See "remarks" | Sale+OE | 216,892 | $28.73 | $6,230,754.39 | -51.6% | +10.3% | - | |
| Nov 26, 2025 | Mignone Roberto | Director | Sell | 50,000 | $26.03 | $1,301,505.00 | -10.1% | +28.9% | - | |
| Nov 20, 2025 | Fox Christine | EVP, Head Of U.s. Commercial | Sale+OE | 28,229 | $24.78 | $699,523.09 | -30.7% | +40.5% | - | |
| Nov 14, 2025 | Fox Christine | EVP, Head Of U.s. Commercial | Sell | 30,000 | $25.11 | $753,321.00 | -51.4% | +33.5% | - | |
| Nov 6, 2025 | Mignone Roberto | Director | Sell | 200,000 | $24.11 | $4,821,880.00 | -28.8% | +42.9% | - | |
| Nov 6, 2025 | Weiss Amir | Chief Accounting Officer | Sell | 12,300 | $24.44 | $300,564.03 | -40.7% | +42.9% | - | |
| Sep 5, 2025 | McAvoy David R. | EVP, Chief Legal Officer | Buy | 1,113 | $18.86 | $20,988.06 | +9.3% | +49.9% | - |